Sarowar Golam

599 total citations
14 papers, 392 citations indexed

About

Sarowar Golam is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Sarowar Golam has authored 14 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Rheumatology. Recurrent topics in Sarowar Golam's work include Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Sarowar Golam is often cited by papers focused on Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (6 papers) and Inhalation and Respiratory Drug Delivery (5 papers). Sarowar Golam collaborates with scholars based in Sweden, United Kingdom and United States. Sarowar Golam's co-authors include Xiao Xu, David Price, Trung N. Tran, Marjan Kerkhof, Joan B. Soriano, Elizabeth V. Hillyer, Don Husereau, Arnaud Bourdin, Nicolas Molinari and Mohd Kashif Siddiqui and has published in prestigious journals such as European Respiratory Journal, Thorax and Allergy.

In The Last Decade

Sarowar Golam

13 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarowar Golam Sweden	9	344	261	75	67	65	14	392
Laurence Gozalo United States	6	262 0.8×	262 1.0×	51 0.7×	40 0.6×	31 0.5×	14	351
Paul G. Solari United States	11	226 0.7×	173 0.7×	32 0.4×	92 1.4×	42 0.6×	20	443
Tracy Bridges United States	3	259 0.8×	252 1.0×	22 0.3×	107 1.6×	26 0.4×	3	332
P. Jane McDowell United Kingdom	8	213 0.6×	174 0.7×	43 0.6×	42 0.6×	46 0.7×	16	309
Amr Radwan United States	11	283 0.8×	168 0.6×	86 1.1×	156 2.3×	79 1.2×	42	474
Martin Plaisance Canada	4	123 0.4×	366 1.4×	27 0.4×	23 0.3×	47 0.7×	7	408
K. Surrey United Kingdom	4	1.1k 3.2×	816 3.1×	76 1.0×	646 9.6×	127 2.0×	9	1.2k
Carrie E. Bedient United States	8	41 0.1×	36 0.1×	132 1.8×	6 0.1×	106 1.6×	11	419
Randall Winnette United States	8	58 0.2×	112 0.4×	33 0.4×	2 0.0×	35 0.5×	19	308

Countries citing papers authored by Sarowar Golam

Since Specialization

Citations

This map shows the geographic impact of Sarowar Golam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarowar Golam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarowar Golam more than expected).

Fields of papers citing papers by Sarowar Golam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarowar Golam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarowar Golam. The network helps show where Sarowar Golam may publish in the future.

Co-authorship network of co-authors of Sarowar Golam

This figure shows the co-authorship network connecting the top 25 collaborators of Sarowar Golam. A scholar is included among the top collaborators of Sarowar Golam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarowar Golam. Sarowar Golam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Xu, Xiao, Trung N. Tran, Sarowar Golam, Victoria Carter, & David Price. (2024). Systemic corticosteroid dose–response effects in asthma: an observational cohort study. ERJ Open Research. 11(1). 172–2024.

Stirnadel-Farrant, Heide A., et al.. (2023). Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK. Rheumatology and Therapy. 10(5). 1167–1182. 3 indexed citations

Stirnadel-Farrant, Heide A., et al.. (2023). Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK. Rheumatology and Therapy. 10(5). 1183–1197. 2 indexed citations

Bruce, Ian N, Sarowar Golam, Evelyn Worthington, et al.. (2022). Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus. Journal of Comparative Effectiveness Research. 11(10). 765–777. 15 indexed citations

Sadatsafavi, Mohsen, J. Mark FitzGerald, Paul M. O’Byrne, et al.. (2021). The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada. Allergy Asthma and Clinical Immunology. 17(1). 108–108. 9 indexed citations

Golam, Sarowar, et al.. (2021). S5 Mortality analyses on systemic corticosteroid use: a long-term observational study. Aberdeen University Research Archive (Aberdeen University). A7.2–A8. 2 indexed citations

FitzGerald, J. Mark, et al.. (2020). The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK. Respiratory Medicine. 171. 106079–106079. 16 indexed citations

Bourdin, Arnaud, Don Husereau, Nicolas Molinari, et al.. (2020). Matching‐adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics. Clinical & Experimental Allergy. 50(4). 442–452. 17 indexed citations

Andersson, Maria, Christer Janson, Thomas Bjerring Kristensen, Ágota Szende, & Sarowar Golam. (2020). Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid–dependent asthma in Sweden. Journal of Medical Economics. 23(8). 877–884. 12 indexed citations

10.

Andersson, Martin, C. Janson, Thomas Kielsgaard Kristensen, Ágota Szende, & Sarowar Golam. (2019). PRS24 COST EFFECTIVENESS OF BENRALIZUMAB FOR SEVERE, UNCONTROLLED ORAL CORTICOSTEROID-DEPENDENT ASTHMA IN SWEDEDN. Value in Health. 22. S876–S877. 1 indexed citations

11.

Bourdin, Arnaud, Don Husereau, Nicolas Molinari, et al.. (2018). Matching-adjusted indirect comparison of benralizumabversusinterleukin-5 inhibitors for the treatment of severe asthma: a systematic review. European Respiratory Journal. 52(5). 1801393–1801393. 66 indexed citations

12.

Voorham, Jaco, Xiao Xu, David Price, et al.. (2018). Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy. 74(2). 273–283. 73 indexed citations

13.

Chen, Stephanie, et al.. (2018). Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Current Medical Research and Opinion. 34(12). 2075–2088. 68 indexed citations

14.

Kerkhof, Marjan, Trung N. Tran, Joan B. Soriano, et al.. (2017). Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population. Thorax. 73(2). 116–124. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact